Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Prior to Intubation in Neonates
NCT05304598Phase 3Withdrawn
- Sponsor
- Maimonides Medical Center
- Start
- Mar 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in Procedural sedation (PS), sponsored by Maimonides Medical Center. Planned start Mar 2022; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05304598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05304598.